Yescarta

ASH: Gilead touts 'astounding' Yescarta survival results at 3 years
Fierce Pharma
Sun, 12/8/19 - 10:13 pm
Gilead Sciences
Yescarta
ASH2019
CAR-T
refractory large B-cell lymphoma
Celgene posts pivotal CAR-T data ahead of FDA filing
Fierce Biotech
Thu, 11/7/19 - 10:28 am
Celgene
CAR-T
liso-cel
Kymriah
Yescarta
Gilead third-quarter results in line, but Yescarta sales dip
Yahoo/Reuters
Thu, 10/24/19 - 11:27 pm
Gilead Sciences
earnings
Yescarta
Expensive Gilead, Novartis cancer therapies losing patients to experimental treatments
Yahoo/Reuters
Tue, 07/30/19 - 07:51 am
lymphoma
Gilead Siences
Novartis
cell therapies
Kymriah
Yescarta
Gilead's Kite builds cell therapy manufacturing quickly even as Yescarta sales grow slowly
Fierce Pharma
Tue, 07/16/19 - 10:54 am
Gilead Sciences
Kte Pharma
Yescarta
CAR-T
cell therapy
Gilead highlights Yescarta survival data in ASCO update
Pharmaforum
Mon, 06/3/19 - 07:46 pm
Gilead Sciences
clinical trials
Yescarta
relapsed or refractory diffuse large B-cell lymphoma
ASCO 2019
Medicare would cover CAR-T cell therapies under new CMS proposal
Marketwatch
Fri, 02/15/19 - 12:22 pm
Medicare
CAR-T
cell therapy
CMS
Novartis
Kymriah
Gilead Sciences
Yescarta
For CAR-T Cancer Fighters in the Real World, Two Roads Diverge
Xconomy
Thu, 01/3/19 - 04:16 pm
cancer
CAR-T
Gilead Sciences
Yescarta
Novartis
Kymriah
2 Sets of Disasters Biotech Will Pay For in 2019
Yahoo/Motley Fool
Mon, 12/17/18 - 12:16 am
Gilead Sciences
Yescarta
Novartis
Kymriah
Spark Therapeutics
Luxturna
ASH: Gilead, Novartis tout long-term data for CAR-T slow starters Yescarta, Kymriah
Fierce Pharma
Sun, 12/2/18 - 11:01 pm
Gilead
Novartis
CAR-T
Yescarta
Kymriah
ASH2018
NHS, Gilead reach agreement for Yescarta
BioCentury
Sat, 10/6/18 - 12:50 pm
Yescarta
Gilead Sciences
UK
NHS
CAR-T
UK rejects Gilead's CAR-T cancer cell therapy as too expensive
Reuters
Tue, 08/28/18 - 11:51 am
Yescarta
UK
Europe
CAR-T
NICE
Gilead Sciences
Kite Receives Positive Opinion from CHMP for Yescarta in Lymphoma
CP Wire
Fri, 06/29/18 - 09:50 am
Kite Pharma
Gilead Sciences
EMA
CHMP
Yescarta
B-cell lymphoma
Could an old Amgen-developed RA drug make CAR-T treatments safer?
Fierce Biotech
Thu, 06/7/18 - 10:08 am
CAR-T
cytokine release syndrome
Kymriah
Yescarta
Amgen
Kineret
Gilead finds new home in Europe for CAR-T manufacturing
Biopharma Dive
Tue, 05/15/18 - 11:43 am
Gilead Sciences
Netherlands
Yescarta
drug manufacturing
New approval sets up CAR-T showdown for Gilead, Novartis
Biopharma Dive
Wed, 05/2/18 - 10:00 pm
Kymriah
Novartis
cell therapy
Yescarta
Gilead Sciences
Medicare sets outpatient rate for Yescarta reimbursement
Reuters
Fri, 04/6/18 - 10:06 am
Medicare
Yescarta
reimbursement
Gilead Sciences
5 Drugs That Are Critical for Gilead Sciences' Future
Motley Fool
Thu, 02/22/18 - 09:18 am
Gilead Sciences
Biktarvy
Yescarta
selonsertib
filgotinib
Epclusa
ICER declares costs of approved CAR-T therapies aligned with clinical benefit
BioWorld
Tue, 02/20/18 - 09:58 am
CAR-T
ICER
Gilead Sciences
Yescarta
Novartis
Kymriah
drug pricing
Beefing up its CAR-T pipeline, Gilead teams up with Pfizer on a lymphoma combo
Endpoints
Thu, 01/18/18 - 10:06 am
CAR-T
Gilead Sciences
Pfizer
utomilumab
Yescarta
large B-cell lymphoma

Pages